Single Arm Phase Ib/II Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer: Big Ten Cancer Research Consortium BTCRC-GU16-043

Learn more:

• clinicaltrials.gov: #NCT03308396
• See Study Locations on Big Ten CRC Website